Ma, Xiaodong et al. published their patent in 2017 |CAS: 16230-24-3

The Article related to phosphoryl pyrimidine compound preparation antitumor activity, Organometallic and Organometalloidal Compounds: Phosphorus Compounds and other aspects.Application In Synthesis of N-(3-Aminophenyl)acrylamide

On April 19, 2017, Ma, Xiaodong; Ge, Yang; Song, Zhendong; Huang, Shanshan; Wang, Changyuan; Zhang, Jianbin; Tang, Zeyao; Liu, Kexin published a patent.Application In Synthesis of N-(3-Aminophenyl)acrylamide The title of the patent was Phosphoryl pyrimidine compound, and its composition and application. And the patent contained the following:

The title phosphoryl pyrimidine compound is shown in formula I, wherein, X is Cl or F; L is -CH2- or -O(CH2)2CH2-; R1 is selected from H, Me, methoxy, and Cl; R2 is selected from methoxy, ethoxy, etc.; R3 is methoxy, ethoxy, etc. The phosphoryl pyrimidine compound is capable of inhibiting Brutons tyrosine kinase, so as to treat tumor diseases, such as Burkitts lymphoma, diffuse large B cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia. The experimental process involved the reaction of N-(3-Aminophenyl)acrylamide(cas: 16230-24-3).Application In Synthesis of N-(3-Aminophenyl)acrylamide

The Article related to phosphoryl pyrimidine compound preparation antitumor activity, Organometallic and Organometalloidal Compounds: Phosphorus Compounds and other aspects.Application In Synthesis of N-(3-Aminophenyl)acrylamide

Referemce:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics